See more : Jupiter Mines Limited (JMS.AX) Income Statement Analysis – Financial Results
Complete financial analysis of HealthEquity, Inc. (HQY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of HealthEquity, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Guangdong Failong Crystal Technology Co.,LTD. (300460.SZ) Income Statement Analysis – Financial Results
- Unilumin Group Co., Ltd (300232.SZ) Income Statement Analysis – Financial Results
- Khimprom Public Joint stock company (HIMCP.ME) Income Statement Analysis – Financial Results
- SIIC Environment Holdings Ltd. (0807.HK) Income Statement Analysis – Financial Results
- MFC-Nichada Thani Property Fund 2 (MNIT.BK) Income Statement Analysis – Financial Results
HealthEquity, Inc. (HQY)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.healthequity.com
About HealthEquity, Inc.
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. The company was incorporated in 2002 and is headquartered in Draper, Utah.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 999.59M | 861.75M | 756.56M | 733.57M | 531.99M | 287.24M | 229.53M | 178.37M | 126.79M | 87.86M | 62.02M | 46.09M |
| Cost of Revenue | 376.95M | 371.66M | 332.85M | 318.24M | 206.08M | 106.05M | 94.61M | 72.02M | 54.19M | 39.88M | 29.21M | 21.97M |
| Gross Profit | 622.64M | 490.09M | 423.71M | 415.33M | 325.91M | 181.19M | 134.92M | 106.36M | 72.60M | 47.97M | 32.80M | 24.12M |
| Gross Profit Ratio | 62.29% | 56.87% | 56.00% | 56.62% | 61.26% | 63.08% | 58.78% | 59.63% | 57.26% | 54.60% | 52.89% | 52.33% |
| Research & Development | 218.81M | 193.38M | 157.36M | 124.81M | 77.58M | 35.06M | 27.39M | 22.38M | 16.83M | 10.50M | 7.14M | 4.23M |
| General & Administrative | 103.66M | 95.63M | 84.38M | 84.49M | 60.56M | 33.04M | 25.11M | 20.15M | 14.11M | 8.34M | 3.90M | 3.37M |
| Selling & Marketing | 79.27M | 68.85M | 58.61M | 49.96M | 43.95M | 29.50M | 23.14M | 18.32M | 13.30M | 10.62M | 8.60M | 7.80M |
| SG&A | 182.93M | 164.48M | 142.98M | 134.46M | 104.51M | 62.54M | 48.25M | 38.47M | 27.42M | 18.96M | 12.50M | 11.16M |
| Other Expenses | 0.00 | 94.59M | 82.79M | 76.06M | 34.70M | -1.85M | -2.23M | -1.09M | -589.00K | -374.00K | -129.00K | -147.00K |
| Operating Expenses | 401.74M | 452.44M | 383.14M | 335.33M | 216.79M | 103.52M | 80.50M | 65.14M | 46.46M | 31.10M | 21.28M | 17.03M |
| Cost & Expenses | 871.45M | 824.10M | 715.99M | 653.57M | 422.88M | 209.57M | 175.11M | 137.16M | 100.64M | 70.98M | 50.49M | 39.00M |
| Interest Income | 12.14M | 1.76M | 1.50M | 1.05M | 5.91M | 1.68M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 55.46M | 48.42M | 36.57M | 34.88M | 24.77M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 44.00K | 326.00K |
| Depreciation & Amortization | 153.08M | 161.20M | 137.19M | 115.90M | 55.35M | 18.19M | 15.95M | 13.19M | 8.60M | 1.64M | 4.27M | 3.37M |
| EBITDA | 282.42M | 171.53M | 102.97M | 154.93M | 123.28M | 94.00M | 68.14M | 54.40M | 34.74M | 22.76M | 15.79M | 10.19M |
| EBITDA Ratio | 28.25% | 23.22% | 22.71% | 27.15% | 29.21% | 33.37% | 30.66% | 30.50% | 27.40% | 20.64% | 25.26% | 22.37% |
| Operating Income | 128.13M | 38.92M | 34.64M | 83.28M | 77.01M | 77.67M | 54.42M | 41.21M | 26.14M | 16.87M | 11.52M | 7.09M |
| Operating Income Ratio | 12.82% | 4.52% | 4.58% | 11.35% | 14.48% | 27.04% | 23.71% | 23.10% | 20.62% | 19.21% | 18.58% | 15.39% |
| Total Other Income/Expenses | -53.09M | -47.15M | -42.50M | -29.87M | -33.85M | -1.85M | -2.23M | -1.09M | -589.00K | -1.11M | -6.15M | -590.00K |
| Income Before Tax | 75.04M | -38.10M | -66.74M | 4.14M | 43.16M | 75.82M | 52.19M | 40.12M | 25.55M | 15.76M | 5.37M | 6.50M |
| Income Before Tax Ratio | 7.51% | -4.42% | -8.82% | 0.56% | 8.11% | 26.40% | 22.74% | 22.49% | 20.16% | 17.94% | 8.67% | 14.11% |
| Income Tax Expense | 19.33M | -11.95M | -22.45M | -4.69M | 3.49M | 1.92M | 4.83M | 13.74M | 8.94M | 5.60M | 4.14M | -4.67M |
| Net Income | 55.71M | -26.14M | -44.29M | 8.83M | 39.66M | 73.90M | 47.36M | 26.38M | 16.61M | 10.17M | 1.23M | 11.17M |
| Net Income Ratio | 5.57% | -3.03% | -5.85% | 1.20% | 7.46% | 25.73% | 20.63% | 14.79% | 13.10% | 11.57% | 1.99% | 24.23% |
| EPS | 0.65 | -0.31 | -0.53 | 0.12 | 0.59 | 1.20 | 0.79 | 0.45 | 0.29 | 0.39 | -1.26 | 0.51 |
| EPS Diluted | 0.64 | -0.31 | -0.53 | 0.12 | 0.58 | 1.17 | 0.77 | 0.44 | 0.28 | 0.21 | -1.26 | 0.21 |
| Weighted Avg Shares Out | 85.56M | 84.44M | 83.13M | 74.24M | 67.03M | 61.84M | 60.30M | 58.62M | 56.72M | 31.18M | 5.65M | 7.76M |
| Weighted Avg Shares Out (Dil) | 86.96M | 84.44M | 83.13M | 75.68M | 68.45M | 63.37M | 61.85M | 59.89M | 58.86M | 51.86M | 5.65M | 45.85M |
Reasons Why You Should Retain HealthEquity (HQY) Stock for Now
Benefits Leaders Believe in Power of AI, Considering Data Privacy and Accuracy
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term
HealthEquity (HQY) Q4 Earnings Surpass Estimates, Margins Up
HealthEquity, Inc. (HQY) Q4 2024 Earnings Call Transcript
Compared to Estimates, HealthEquity (HQY) Q4 Earnings: A Look at Key Metrics
HealthEquity (HQY) Beats Q4 Earnings and Revenue Estimates
HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2024 Financial Results
Here's Why You Should Retain HealthEquity (HQY) Stock Now
Here's Why HealthEquity (HQY) is a Strong Momentum Stock
Source: https://incomestatements.info
Category: Stock Reports